Skip to content
Lucero Bio
Precision 3D cell culture handling, at scale.
Lucero BioLucero Bio
  • Home
  • About
  • Technology
  • EIC Transition Project
  • Applications
  • News
  • Contact
Search:
Linkedin page opens in new windowInstagram page opens in new window
  • Home
  • About
  • Technology
  • EIC Transition Project
  • Applications
  • Contact
  • News

Daily Archives: June 1, 2021

You are here:
  1. Home
  2. 2021
  3. June
  4. 01

Lucero joins Nanoscale Drug Testing consortium

Company, Media, New ProjectBy LuceroJune 1, 2021

The consortium aims to develop a “near-patient drug development” strategy that includes using 3D cell models comprised of patient-derived cells. The strategy will reduce clinical failures, enable the development of more effective treatments at a lower cost, and allow the right drug leads to be matched with the right patient subgroup.

Lucero Bio
© Lucero AB- 2023. All rights reserved.
  • Home
  • About
  • Technology
  • News
  • EIC Transition Project
  • Contact
All menus
Go to Top